Media Coverage
How decades of NCI support led to groundbreaking discoveries: the story of immune checkpoint inhibitors
Icon
OncoDaily
Pembrolizumab monotherapy shows promise in desmoplastic melanoma
Icon
Oncology Times
Rare melanoma trial serves as model for advancing cancer immunotherapy
Icon
Targeted Oncology
Cancer in 2026: How immunotherapy is reshaping the odds
Icon
Cancer Research Institute
Neoadjuvant immunotherapy ‘a true shift’ in treatment for aggressive form of skin cancer
Icon
Healio
Approved immunotherapy shrinks, eliminates rare, aggressive melanoma, clinical trial finds
Icon
Health Day
NIH budget cuts threaten the future of biomedical research — and the young scientists behind it
Icon
Los Angeles Times
Novel insights on how immune cells respond to cancer cells uncovered
Icon
Genetic Engineering & Biotechnology News